[DPHARMA] QoQ Cumulative Quarter Result on 30-Sep-2018 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
28-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Sep-2018 [#3]
Profit Trend
QoQ- 58.54%
YoY- 8.65%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 295,852 150,386 498,722 383,088 257,250 133,259 467,987 -26.40%
PBT 37,102 18,786 59,666 42,008 26,170 13,255 51,796 -19.99%
Tax -8,721 -4,321 -12,025 -8,736 -5,184 -2,608 -9,696 -6.83%
NP 28,381 14,465 47,641 33,272 20,986 10,647 42,100 -23.17%
-
NP to SH 28,381 14,465 47,641 33,272 20,986 10,782 42,492 -23.64%
-
Tax Rate 23.51% 23.00% 20.15% 20.80% 19.81% 19.68% 18.72% -
Total Cost 267,471 135,921 451,081 349,816 236,264 122,612 425,887 -26.72%
-
Net Worth 503,029 496,410 483,173 501,487 209,983 206,429 479,809 3.20%
Dividend
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Div 6,618 - 36,403 9,897 4,199 - 23,711 -57.39%
Div Payout % 23.32% - 76.41% 29.75% 20.01% - 55.80% -
Equity
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Net Worth 503,029 496,410 483,173 501,487 209,983 206,429 479,809 3.20%
NOSH 661,881 661,881 661,881 661,881 650,902 278,959 278,959 78.17%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 9.59% 9.62% 9.55% 8.69% 8.16% 7.99% 9.00% -
ROE 5.64% 2.91% 9.86% 6.63% 9.99% 5.22% 8.86% -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 44.70 22.72 75.35 58.06 91.88 47.77 167.76 -58.69%
EPS 4.26 2.19 7.26 5.09 3.22 3.82 15.09 -57.06%
DPS 1.00 0.00 5.50 1.50 1.50 0.00 8.50 -76.08%
NAPS 0.76 0.75 0.73 0.76 0.75 0.74 1.72 -42.07%
Adjusted Per Share Value based on latest NOSH - 661,881
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 30.73 15.62 51.81 39.79 26.72 13.84 48.61 -26.40%
EPS 2.95 1.50 4.95 3.46 2.18 1.12 4.41 -23.56%
DPS 0.69 0.00 3.78 1.03 0.44 0.00 2.46 -57.25%
NAPS 0.5225 0.5157 0.5019 0.5209 0.2181 0.2144 0.4984 3.20%
Price Multiplier on Financial Quarter End Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 -
Price 1.37 1.28 0.95 1.23 1.30 2.80 2.53 -
P/RPS 3.06 5.63 1.26 2.12 1.41 5.86 1.51 60.34%
P/EPS 31.95 58.57 13.20 24.39 17.34 72.44 16.61 54.85%
EY 3.13 1.71 7.58 4.10 5.77 1.38 6.02 -35.41%
DY 0.73 0.00 5.79 1.22 1.15 0.00 3.36 -63.96%
P/NAPS 1.80 1.71 1.30 1.62 1.73 3.78 1.47 14.49%
Price Multiplier on Announcement Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 30/08/19 21/05/19 18/02/19 28/11/18 26/11/18 28/05/18 28/02/18 -
Price 1.41 1.36 1.03 1.07 1.08 3.35 2.97 -
P/RPS 3.15 5.99 1.37 1.84 1.18 7.01 1.77 47.01%
P/EPS 32.88 62.23 14.31 21.22 14.41 86.67 19.50 41.80%
EY 3.04 1.61 6.99 4.71 6.94 1.15 5.13 -29.51%
DY 0.71 0.00 5.34 1.40 1.39 0.00 2.86 -60.60%
P/NAPS 1.86 1.81 1.41 1.41 1.44 4.53 1.73 4.96%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment